SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis

BACKGROUND: Patients with inflammatory bowel disease (IBD) have an attenuated serologic response to COVID-19 vaccination. It is unclear whether an impaired immune response in vaccinated IBD patients impacts the susceptibility to SARS-CoV-2 infection and occurrence of severe COVID-19. OBJECTIVES: To...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Pol, Natasja, Pan, Qiuwei, Derikx, Lauranne A. A. P., Bakker, Linda, van der Woude, C. Janneke, de Vries, Annemarie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
The Impact of COVID-19 in Gastrointestinal Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350577/
https://www.ncbi.nlm.nih.gov/pubmed/37461739
http://dx.doi.org/10.1177/17562848231174295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350577/
https://www.ncbi.nlm.nih.gov/pubmed/37461739
http://dx.doi.org/10.1177/17562848231174295

Ejemplares similares